Janus kinase (JAK) inhibition with baricitinib in refractory juvenile dermatomyositis | Annals of the Rheumatic Diseases

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Current issue

Archive

Authors

About

Podcasts
Subscribe
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Article metrics

Letter

Janus kinase (JAK) inhibition with baricitinib in refractory juvenile dermatomyositis

Online download statistics by month:

Online download statistics by month: August 2020 to March 2024

	Abstract	Full	Pdf
Aug 2020	1690	268	52
Sep 2020	2064	235	117
Oct 2020	1527	128	69
Nov 2020	842	64	39
Dec 2020	375	41	31
Jan 2021	357	38	22
Feb 2021	1000	91	67
Mar 2021	870	89	70
Apr 2021	392	60	43
May 2021	239	41	28
Jun 2021	67	43	32
Jul 2021	50	38	34
Aug 2021	75	51	34
Sep 2021	65	39	31
Oct 2021	304	53	27
Nov 2021	296	42	19
Dec 2021	262	36	25
Jan 2022	230	25	18
Feb 2022	453	29	23
Mar 2022	311	23	15
Apr 2022	399	25	19
May 2022	223	27	8
Jun 2022	251	23	12
Jul 2022	423	28	15
Aug 2022	155	27	12
Sep 2022	195	25	10
Oct 2022	157	27	11
Nov 2022	260	39	14
Dec 2022	177	16	10
Jan 2023	170	32	12
Feb 2023	206	33	18
Mar 2023	322	44	25
Apr 2023	230	18	9
May 2023	142	19	17
Jun 2023	175	13	8
Jul 2023	205	13	7
Aug 2023	148	27	5
Sep 2023	195	38	14
Oct 2023	264	25	7
Nov 2023	216	27	15
Dec 2023	226	12	9
Jan 2024	212	23	31
Feb 2024	312	9	6
Mar 2024	151	23	10
Total	16883	2027	1100